GSK hires Rapp for global NiQuitin CQ and Alli accounts
By Matt Williams, campaignlive.co.uk, Thursday, 11 June 2009 06:30AM
LONDON - GlaxoSmithKline, the healthcare giant, has handed Rapp the global direct marketing and digital accounts for its NiQuitin CQ and Alli brands after a pitch against LBi, Razorfish and EHS Brann.
The review was first called in April, and was handled by Agency Assessments.
In the UK, Rapp does not currently work with any GSK brands, but in the US it already handles the Alli range.
The agency will now be responsible for developing each brand's global strategies, working across direct marketing, digital, CRM and eCRM.
The first pieces of work, which will include the launch of a new website, are expected to roll out in the autumn.
NiQuitin's current below-the-line work is built around its Click2Quit scheme, which offers consumers advice to help them give up smoking.
The campaign gives users the ability to create their own personal plan to help them stop smoking, and informs them about the NiQuitin products that are on offer.
This article was first published on campaignlive.co.uk
- Senior Digital Designer Twist Recruitment £35000 - £42000 per annum + benefits, City of London
- Head of CRM/Customer Experience - 8/9 month Contract ADLIB Competitive + Benefits, Devon
- Digital Executive - Fluent French & Dutch Barclay Meade £200 - £250 per day, Berkshire
- SEO Consultant The Little Black Book Agency £20000 - £25000 per annum, Greater Manchester
- Interactive / Digital Designer The Little Black Book Agency £25000 - £35000 per annum, Greater Manchester
- Samsung calls global advertising and media review
- Watch the first YouTube clip, nine years on
- British Airways moves paid search account to Forward3D
- M&C Saatchi's Enyi Nwosu takes global role at Mindshare
- Post Office reviews advertising, DM and digital accounts
- Karmarama grabs Coppafeel! breast cancer charity account